Cancer molecular markers: A guide to cancer detection and management
- PMID: 29428478
- DOI: 10.1016/j.semcancer.2018.02.002
Cancer molecular markers: A guide to cancer detection and management
Abstract
Cancer is generally caused by the molecular alterations which lead to specific mutations. Advances in molecular biology have provided an impetus to the study of cancers with valuable prognostic and predictive significance. Over the hindsight various attempts have been undertaken by scientists worldwide, in the management of cancer; where, we have witnessed a number of molecular markers which allow the early detection of cancers and lead to a decrease in its mortality rate. Recent advances in oncology have led to the discovery of cancer markers that has allowed early detection and targeted therapy of tumors. In this context, current review provides a detail outlook on various molecular markers for diagnosis, prognosis and management of therapeutic response in cancer patients.
Keywords: Biomarkers; Genomics; Molecular markers; NGS; Personalized cancer medicine.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Similar articles
-
[Cancer: three eras of personalized medicine].Med Sci (Paris). 2017 Oct;33(10):905-908. doi: 10.1051/medsci/20173310024. Epub 2017 Oct 10. Med Sci (Paris). 2017. PMID: 28994388 French.
-
Delivering on the promise of precision cancer medicine.Genome Med. 2016 Oct 25;8(1):110. doi: 10.1186/s13073-016-0373-1. Genome Med. 2016. PMID: 27782852 Free PMC article. No abstract available.
-
Brave-ish New World--What's Needed to Make Precision Oncology a Practical Reality.JAMA Oncol. 2015 Oct;1(7):879-80. doi: 10.1001/jamaoncol.2015.1540. JAMA Oncol. 2015. PMID: 26181886 No abstract available.
-
Epigenetics and Precision Oncology.Cancer J. 2017 Sep/Oct;23(5):262-269. doi: 10.1097/PPO.0000000000000281. Cancer J. 2017. PMID: 28926426 Free PMC article. Review.
-
Molecular Tumor Boards in Clinical Practice.Trends Cancer. 2020 Sep;6(9):738-744. doi: 10.1016/j.trecan.2020.05.008. Epub 2020 Jun 6. Trends Cancer. 2020. PMID: 32517959
Cited by
-
Integrated Bioinformatics Analysis for Identifying the Significant Genes as Poor Prognostic Markers in Gastric Adenocarcinoma.J Oncol. 2022 Jun 11;2022:9080460. doi: 10.1155/2022/9080460. eCollection 2022. J Oncol. 2022. PMID: 35726219 Free PMC article.
-
Artificial intelligence methods available for cancer research.Front Med. 2024 Oct;18(5):778-797. doi: 10.1007/s11684-024-1085-3. Epub 2024 Aug 8. Front Med. 2024. PMID: 39115792 Review.
-
Salivary biomarkers for cancer diagnosis: a meta-analysis.Ann Med. 2020 May-Jun;52(3-4):131-144. doi: 10.1080/07853890.2020.1730431. Epub 2020 Apr 11. Ann Med. 2020. PMID: 32056455 Free PMC article.
-
Phototherapy Combined with Carbon Nanomaterials (1D and 2D) and their Applications in Cancer Therapy.Materials (Basel). 2020 Oct 28;13(21):4830. doi: 10.3390/ma13214830. Materials (Basel). 2020. PMID: 33126750 Free PMC article. Review.
-
Enhanced and Interpretable Prediction of Multiple Cancer Types Using a Stacking Ensemble Approach with SHAP Analysis.Bioengineering (Basel). 2025 Apr 29;12(5):472. doi: 10.3390/bioengineering12050472. Bioengineering (Basel). 2025. PMID: 40428091 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources